16 September 2026 editorial review · Item
Ultra-rapid lispro (Lyumjev): review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Ultra-rapid lispro (Lyumjev)
Scope and findings:
- Read current June 2026 label: mealtime/within20 minutes, U100-only pump/IV, U200pen-only,no syringe transfer. Corrected ambiguous U200vial/IV wording. Exact pump compatibility follows both labels; exercise RCT and global prices not freshly revalidated.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.